[Possibilities of controlling the cardiovascular side effects of ketamine. Experimental and clinical study].
D000328:Adult; D000771:Anesthesia, Intravenous / Q000009:adverse effects*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control; D007649:Ketamine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D005996:Nitroglycerin / Q000627:therapeutic use*; D011229:Preanesthetic Medication / Q000379:methods*; D011652:Pulmonary Circulation / Q000187:drug effects; D011817:Rabbits
D007649:Ketamine; D005996:Nitroglycerin
Possibilità di controllo degli effetti secondari cardiovascolari della ketamina. Studio sperimentale e clinico.